Cargando…

Cost-effectiveness modelling of birth and infant dose vaccination against hepatitis B virus in Ontario from 2020 to 2050

BACKGROUND: The World Health Organization recommends universal birth dose vaccination for hepatitis B virus (HBV), yet only 3 provinces and territories in Canada provide birth dose vaccination, and Canadian-born children in Ontario are acquiring HBV before adolescent vaccination. We sought to determ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Biondi, Mia J., Estes, Chris, Razavi-Shearer, Devin, Sahdra, Kanwar, Lipton, Nechama, Shah, Hemant, Capraru, Camelia, Janssen, Harry L.A., Razavi, Homie, Feld, Jordan J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	CMA Impact Inc. 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842099/ https://www.ncbi.nlm.nih.gov/pubmed/36627129 http://dx.doi.org/10.9778/cmajo.20210284

Ejemplares similares

The impact of immigration on hepatitis B burden in the United States: a modelling study
por: Razavi-Shearer, Devin, et al.
Publicado: (2023)

Modelling hepatitis B virus infection and impact of timely birth dose vaccine: A comparison of two simulation models
por: de Villiers, Margaret J., et al.
Publicado: (2020)

Liver Disease Burden of Hepatitis C Virus Infection in Iran and the Potential Impact of Various Treatment Strategies on the Disease Burden
por: Hajarizadeh, Behzad, et al.
Publicado: (2016)

Progress Toward Hepatitis B and Hepatitis C Elimination Using a Catalytic Funding Model — Tashkent, Uzbekistan, December 6, 2019–March 15, 2020
por: Dunn, Rick, et al.
Publicado: (2020)

Impact of COVID-19 on global HCV elimination efforts
por: Blach, Sarah, et al.
Publicado: (2021)

Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
por: Estes, Chris, et al.
Publicado: (2017)

Hepatitis C elimination in Sweden: Progress, challenges and opportunities for growth in the time of COVID‐19
por: Blach, Sarah, et al.
Publicado: (2021)

HCV infection prevalence in a population recruited at health centers in Jordan
por: Hamoudi, Waseem, et al.
Publicado: (2013)

Remaining challenges in HCV elimination
por: Capraru, Camelia, et al.
Publicado: (2021)

Chronic Hepatitis C Virus (HCV) Disease Burden and Cost in the United States
por: Razavi, Homie, et al.
Publicado: (2013)

A projection of primary knee replacement in Denmark from 2020 to 2050
por: Daugberg, Louise, et al.
Publicado: (2021)

Modeling HCV elimination recovery following the COVID-19 pandemic in the United States: Pathways to regain progress
por: Blach, Sarah, et al.
Publicado: (2023)

Leveraging corona virus disease 2019 vaccination to promote hepatitis C screening
por: Vanderhoff, Aaron, et al.
Publicado: (2022)

Hydrological projections in the upper reaches of the Yangtze River Basin from 2020 to 2050
por: Huang, Ya, et al.
Publicado: (2021)

Projection of primary and revision hip arthroplasty surgery in Denmark from 2020 to 2050
por: B RASMUSSEN, Mathias, et al.
Publicado: (2022)

Regional energy 2050
por: Herrmann, Nicolai
Publicado: (2011)

Desarrollo Industrial 2050/
por: Oropeza García Arturo

Assessment of Treatment Strategies to Achieve Hepatitis C Elimination in Canada Using a Validated Model
por: Binka, Mawuena, et al.
Publicado: (2020)

Evaluation of Dried Blood Spot Testing for SARS-CoV-2 Serology Using a Quantitative Commercial Assay
por: Brinc, Davor, et al.
Publicado: (2021)

Urgent action to fight hepatitis C in people who inject drugs in Europe
por: Dillon, John F., et al.
Publicado: (2016)

Nonalcoholic fatty liver disease burden: Australia, 2019–2030
por: Adams, Leon A, et al.
Publicado: (2020)

Optimization of hepatitis C virus screening strategies by birth cohort in Italy
por: Kondili, Loreta A., et al.
Publicado: (2020)

HCV elimination among people who inject drugs. Modelling pre- and post–WHO elimination era
por: Gountas, Ilias, et al.
Publicado: (2018)

The Payer License Agreement, or “Netflix model,” for hepatitis C virus therapies enables universal treatment access, lowers costs and incentivizes innovation and competition
por: Matthews, David W., et al.
Publicado: (2022)

A unified physics by 2050?
por: Weinberg, Steven
Publicado: (2003)

Fusion - 2050 perspective (in Polish)
por: Romaniuk, R S
Publicado: (2013)

Spatial distribution estimation of malaria in northern China and its scenarios in 2020, 2030, 2040 and 2050
por: Song, Yongze, et al.
Publicado: (2016)

Estimating the global economic benefits of physically active populations over 30 years (2020–2050)
por: Hafner, Marco, et al.
Publicado: (2020)

Sustainable Futures in the Built Environment to 2050
por: Dixon, Tim
Publicado: (2018)

Is Net Zero Carbon 2050 Possible?
por: Deutch, John
Publicado: (2020)

Changing behaviour for net zero 2050
por: Marteau, Theresa M, et al.
Publicado: (2021)

Europe’s Climate Target for 2050: An Assessment
por: Tol, Richard S. J.
Publicado: (2021)

Mapping of global, regional and national incidence, mortality and mortality-to-incidence ratio of lung cancer in 2020 and 2050
por: Sharma, Rajesh
Publicado: (2022)

Estimates and Projections of the Global Economic Cost of 29 Cancers in 204 Countries and Territories From 2020 to 2050
por: Chen, Simiao, et al.
Publicado: (2023)

PREDICTION OF THE NUMBER OF AND CARE COSTS FOR DISABLED OLDER ADULTS FROM 2020 TO 2050 IN URBAN AND RURAL AREAS IN CHINA
por: zhang, liangwen, et al.
Publicado: (2019)

Possible changes to arable crop yields by 2050
por: Jaggard, Keith W., et al.
Publicado: (2010)

Multiyear interactive computer almanac, 1800-2050
por: United States. Naval Observatory
Publicado: (2005)

Psychiatry 2050: from younger psychiatrists’ perspective
por: Hassan, Tariq Mahmood, et al.
Publicado: (2014)

Intensive care medicine in 2050: the ICU in vivo
por: Ince, Can
Publicado: (2017)

Projected burden of stroke in China through 2050
por: Yao, Minghong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rhlnvlna37m6alufhiph2u6fis